Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 41

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 41
---
, which means that we can disclose important information to you by referring you to
those documents. The information incorporated by reference is an important part of this prospectus. Information in this prospectus supersedes
information incorporated by reference that we filed with the SEC prior to the date of this prospectus, while information that we file
later with the SEC will automatically update and supersede the information in this prospectus to the extent that a statement contained
in this prospectus or free writing prospectus provided to you in connection with this offering, or in any other document we subsequently
file with the SEC that also is incorporated by reference in this prospectus, modifies or supersedes the original statement.

The following documents, which
we have filed with the SEC are incorporated by reference in this prospectus:

All documents subsequently
filed by us pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Exchange Act after the date of this prospectus and prior to the
termination of all offerings covered by this prospectus hereby shall be deemed to be incorporated by reference in this prospectus and
to be part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been
furnished and not filed in accordance with SEC rules shall not be deemed incorporated by reference into this prospectus.

Any statement contained herein
or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified
or superseded for purposes of this prospectus to the extent that a statement contained herein or in any other subsequently filed document
which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified
or superseded shall not be deemed, except as so modified or amended, to constitute a part of this prospectus.

We will furnish without charge
to you, on written or oral request, a copy of any or all of the documents incorporated by reference, including exhibits to these documents.
You should direct any requests for documents by writing us at 5005 McConnell Avenue, Los Angeles, California 90066, Attention: SVP Finance,
or telephoning us at (310) 665-2928.

The SEC maintains a website
that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC
(http://www.sec.gov). In addition, we maintain a website at www.armat